Michelle Hall

Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy.

C. Stedman, P. Read, B. Conway, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic

P. Haber, A. Dunlop, N. Lintzeris, 2020, Harm Reduction Journal.

Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol

I. McGregor, R. Bruno, M. Shanahan, 2018, BMC Psychiatry.

LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence

A. Baker, R. Mcketin, R. Bruno, 2018, BMJ Open.

Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial.

I. McGregor, R. Bruno, J. Copeland, 2020, Drug and alcohol dependence.

Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial.

I. McGregor, R. Bruno, M. Shanahan, 2019, JAMA internal medicine.